ArticleFrontiers in oncology2022

Anti-Angiogenic Drugs Inhibit Interstitial Lung Disease Progression in Patients With Advanced Non-Small Cell Lung Cancer.

Yanning Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.